| Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing VVSR Karri, G Kuppusamy, SV Talluri, SS Mannemala, R Kollipara, ... International journal of biological macromolecules 93, 1519-1529, 2016 | 342 | 2016 |
| Bioavailability of intranasal drug delivery system SB Bhise, AV Yadav, AM Avachat, R Malayandi Asian journal of pharmaceutics 2 (4), 201, 2008 | 102 | 2008 |
| Current and emerging therapies in the management of diabetic foot ulcers VVSR Karri, G Kuppusamy, SV Talluri, K Yamjala, SS Mannemala, ... Current medical research and opinion 32 (3), 519-542, 2016 | 67 | 2016 |
| Effect of HPMC on solubility and dissolution of carbamazepine form III in simulated gastrointestinal fluids SB Bhise, M Rajkumar Asian Journal of Pharmaceutics (AJP) 2 (1), 2008 | 48 | 2008 |
| Multiple biological actions of curcumin in the management of diabetic foot ulcer complications: a systematic review V Karri, K Gowthamarajan, M Satish Kumar, M Rajkumar Trop Med Surg 3 (179), 2, 2015 | 37 | 2015 |
| Terbinafine hydrochloride loaded nanoemulsion based gel for topical application VVSNR Karri, SK Raman, G Kuppusamy, S Mulukutla, S Ramaswamy, ... Journal of Pharmaceutical Investigation 45, 79-89, 2015 | 31 | 2015 |
| Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease R Malayandi, PK Kondamudi, PK Ruby, D Aggarwal Drug delivery and translational research 4, 187-202, 2014 | 29 | 2014 |
| Lidocaine Transdermal Patch: Pharmacokinetic Modeling and In Vitro–In Vivo Correlation (IVIVC) PK Kondamudi, PP Tirumalasetty, R Malayandi, S Mutalik, R Pillai AAPS PharmSciTech 17, 588-596, 2016 | 25 | 2016 |
| Carbamazepine-loaded porous microspheres for short-term sustained drug delivery M Rajkumar, SB Bhise Journal of Young Pharmacists 2 (1), 7-14, 2010 | 23 | 2010 |
| Drugs as causative agents and therapeutic agents in inflammatory bowel disease PK Kondamudi, R Malayandi, C Eaga, D Aggarwal Acta Pharmaceutica Sinica B 3 (5), 289-296, 2013 | 22 | 2013 |
| Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers VVSNR Karri, G Kuppusamy, S Mulukutla, S Sood, R Malayandi Journal of Excipients and Food Chemicals 6 (1), 7-22, 2015 | 11 | 2015 |
| In vitro antifungal activity of a novel allylamine antifungal nanoemulsion gel VVSR Karri, R SK, G Kuppusamy, S BKR Journal of Nanosciences: Current Research, 2018 | 5 | 2018 |
| Controlled nasal delivery of ondansetron HCl SB Bhise, M Rajkumar INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH 41 (3), 229, 2007 | 5 | 2007 |
| Nitrosodimethylamine impurities in metformin drug products: Physician insight C Doshi, R Malayandi, G Namjoshi, P Kadam, D Mule Journal of Diabetology 12 (2), 120-127, 2021 | 4 | 2021 |
| Oral controlled release dosage forms for water soluble drugs MA Chandavarkar, KC Jindal, R Malayandi US Patent App. 13/225,984, 2012 | 4 | 2012 |
| In-situ gel forming solution for ocular drug delivery NM Chandavarkar, KC Jindal, R Malayandi WO2011018800, 2011 | 4 | 2011 |
| Influence of simulated gastrointestinal fluids on polymorphic behavior of anhydrous carbamazepine form III and biopharmaceutical relevance SB Bhise, M Rajkumar PDA journal of pharmaceutical science and technology 64 (1), 28-36, 2010 | 4 | 2010 |
| Establishing postprandial bio-equivalency and IVIVC for generic metformin sustained release small sized tablets C Eaga, S Mantri, R Malayandi, PK Kondamudi, S Chakraborty, SVN Raju, ... Journal of Pharmaceutical Investigation 44, 197-204, 2014 | 3 | 2014 |
| Nanohybrid scaffolds for the treatment of diabetic wounds VVSR Karri, G Kuppusamy, AD Wadhwani, R Malayandi Pressure Injury, Diabetes and Negative Pressure Wound Therapy, 69-108, 2020 | 2 | 2020 |
| Nanodispersion of poorly water soluble drug (s) NM Chandavarkar, KC Jindal, R Malayandi WO Patent 2013098841A1, 2013 | 2 | 2013 |
